Hybrid mesoporous silica SBA-15, with surface incorporated cross-linked long hydrophobic organic bridges was synthesized using stepwise synthesis. The synthesized materials were characterized by elemental analysis, infrared spectroscopy, nuclear magnetic resonance spectroscopy, nitrogen adsorption, X-rays diffraction, thermogravimetry and scanning and transmission electron microscopy. The functionalized material showed highly ordered mesoporous network with a surface area of 629.0 m 2 g -1 . The incorporation of long hydrophobic amine chains on silica surface resulted in high drug loading capacity (21% Mass/Mass) and prolonged release of ibuprofen up till 75.5 h. The preliminary investigations suggests that the synthesized materials could be proposed as controlled release devices to prolong the therapeutic effect of short life drugs such as ibuprofen to increase its efficacy and to reduce frequent dosage.
Introduction
Among porous materials, mesoporous silica (SiO2) has attracted much attention in the recent years due to their highly ordered porous network, extremely high surface area 1500 m 2 g -1 ,
large pore volume and tunable/uniform pore and particle size. The high surface silanol (Si-OH) density of these materials permits the tailoring of the surface properties such as hydrophilicity, and binding of molecular entities. The surface functionalization of SiO2 with organic molecules is emerged as one of the most important research areas in the field of advanced functional materials [1] . The versatile nature of mesoporous SiO2 attracted great deal of attention in various applied fields such as adsorption [2] , catalysis [3] , drug and gene delivery [4, 5] , imprinting for molecular recognition [6] etc.
Controlled release systems have been devised to enable superior control of drug exposure over time, to assist drug in crossing physiological barriers, to shield drug from premature elimination, and to shepherd drug to the desired site of action while minimizing drug exposure elsewhere in the body. These carriers systems may also increase patient compliance by reducing frequency of administration, and may add commercial value to marketed drugs by extending patent protection. Mesoporous silica materials have been intensively investigated as a carrier for controlled and targeted drug release, gene and enzyme immobilization [7] [8] [9] , enabling them to retain their activity after reaching to the specific targeted site. These materials have the significant advantage of being free from various biochemical attacks and bioerosions. In addition to their high drug loading capacity and controlled/sustained release pattern, their biocompatible and nontoxic nature has attracted a great deal of research attention for various controlled release systems [10] .
The physiochemical properties, such as surface charge, surface topography of biomaterials has great influence on its biocompatibility [11, 12] . In mesoporous silica the surface exposed silanol group (about 6% of the total of the particles) can interact with cellular membrane lipids and proteins [13] . Mesoporous silica would rapidly associate with serum opsonin, and then could be removed from circulation by macrophages in reticuloendothelial system (RES) after entering into the blood stream [14] . Some studies also suggest that surface modification plays pivotal role in altering the surface reactivity, improving the biocompatibility and increasing in vivo circulation time [15] . The in vitro cellular uptake and cytotoxicity, in vivo biodistribution and excretion of mesoporous SiO2 can be regulated by surface modification with functional groups such as amino (-NH2), carboxyl (-COOH), phenyl (-Ph), and methyl phosphonate (-PO3  − ) groups [14] . Modified mesoporous SiO2 with amino groups, could manipulate the particle endocytosis [15] .
Among mesoporous silicas, SBA-15 with large surface area up to 1500 m 2 g -1 , pore volume (~1.5 cm 3 g -1 ) and facile surface modification promise great opportunities to obtain functional biomaterials with improved and tailored properties [16] . The large pore diameter of this silica is also important and beneficial for accommodation of large molecular weight enzymes and proteins. SBA-15 has two-dimension hexagonal pore channels that allow loaded drug molecules to directly diffuse outwards. Moreover, both the opposite potential and the similar hydrophilicity between silica and drug molecules also favor the sustained/prolonged release of drugs. Compared to the negatively charged silica, the positive-charge modified silica materials exhibited remarkably sustained release profiles [17] .
Drug loading, generally is a quite complex issue and much efforts were focused on improving drug loading capacity and prolonged therapeutic effect. Surface modification is one of such ways to achieve high drug loading capacity and prolonged/controlled release over an extended time period. Similarly, the diffusion rate of the drug molecules depends on the carrier type [18] . Ibuprofen is an extensively prescribed analgesic and anti-inflammatory drug with a relatively narrow therapeutic range that rapidly eliminate from the body. The efficacy of this drug would be enhanced by protecting it from physiological degradation before absorption. The structure of ibuprofen contains one carboxylic acid group, which can form the stronger bonding with many functional groups such as amines via acid base reaction. Ibuprofen has been also reported as a model drug to study the loading and release profiles from porous systems such as mesoporous silica based carriers. The good pharmacological activity and the suitable molecule size of about 1.0 × 0.6 nm [19] , ensures its easy diffusion into or out of the mesoporous channels of mesoporous silica. Thus the efficacy of this drug would be enhanced by loading it to mesoporous channels of silica to protect it from physiological degradation before absorption.
Hence the aim of this work is to synthesize mesoporous silica SBA-15 with hydrophobic organic functionality for controlled release of ibuprofen. For this purpose modified silica, SBA-15TPA with long hydrophobic chains of tetraethylenepentamine (TPA) was synthesized and tested for the in vitro controlled release of ibuprofen. The sustained/controlled release capacities of the ibuprofen-loaded materials were investigated. The structure and synthesis route of functionalized silica is illustrated in scheme 1.
Experimental

Reagents
All reagents and solvents were of analytical grade and used as received.
Tetraethylorthosilicate (TEOS), 3-chlropropyltriethoxysilane, tetraethylenepentamine (TPA), coblock polymer Pluronic P123, sodium hydroxide (NaOH), sodium chloride (NaCl), sodium bicarbonate (NaHCO3), sodium carbonate (Na2CO3), potassium chloride (KCl), potassium phosphate dibasic trihydrate (K2HPO4.3H2O), magnesium chloride hexahydrate (MgCl2.6H2O), calcium chloride (CaCl2), sodium sulphate (Na2SO4), and tris(hydroxymethyl)aminomethane (NH2C(CH2OH)3, were Sigma Aldrich products. Ethanol, Xylene and HCl were Synth products.
Ibuprofen (IBU) was donated by Galena Pharma Campinas-Brazil and deionized water was used throughout the experiment.
Synthesis of mesoporous silica
Mesoporous silica SBA-15 was synthesized according to a reported method [20] . Briefly, Please insert scheme 1 here.
Drug loading
The drug loading was achieved by soaking the silica samples each 0. 
where m1 is the initial mass of the drug, m2 is the initial mass of silica, C is the concentration of each filtrate diluted in 50.0 cm 3 volumetric flasks, v is sampled volume from filtrate and V is the volume of solvent used for drug loading.
In vitro drug release
In vitro drug release testing is an experimental methodology which is used to characterize and compare the release properties of modified formulations. To provide an accurate estimate of the ibuprofen release from the prepared silicas in-vitro release test/dissolution test was performed using physiological condition. 2). The absorbance of the samples was measured using UV/Vis spectrophotometer.
where Ct-corr is the actual concentration of drug released at time t, Ct is the measured concentration of the release fluid sampled at time t, v is the sampled volume taken at a predetermined time interval, and V is the total volume of release fluid.
Characterization
Fourier transform infrared spectra were obtained by accumulating scans on a Bomem MB- UV/Vis spectrophotometer. To monitor the drug concentration at specific intervals, the mixture was centrifuged at 4000 rpm using a Rotina 38 Hittich Zentrifugen centrifuge. The drug release experiments were performed in an orbital shaking incubator model MA-420-MARCONI-Brazil.
Result and discussion
Elemental analysis
The carbon and nitrogen contents of the modified silica were found 9.14% and 3.58%, 
Infrared Spectroscopy
Typical bands associated with the inorganic backbone of mesoporous silica, as well as with the anchored TPA bridges are shown in Figure 1 . Band appeared at 3500 cm -1 can be attributed to OH stretching frequency, while the bands in the 1620 to 1630 cm -1 interval can be assigned to OH bending vibration of water molecules sorbed onto the solid surface through hydrogen bonds, reinforcing the free silanol groups [23] . Please insert Figure 1 here.
NMR spectroscopy
Resonance of the 29 Figure 2b . The chemical shifts at 9.3; 22; and 48 ppm can be attributed C-Si, C-C, and C-N and assigned to C1-C14 of the inserted proposed structure in Figure 2b , which suggest the successful modification of silica surface.
Please insert Figure 2 here.
Small angle X-ray diffraction
Small angle diffraction (SAXS) patterns of the prepared materials are shown in Figure 3 .
The obtained diffraction patterns indicated that the grafted organic groups did not affect the structural stability of the original mesoporous silica. A sharp reflection at 2θ near to 0.6, indexed as (100) and two minor, but distinct reflections at 2θ in the interval 1.0 to 2.0, were indexed as (110) and (200), respectively. These peaks were indexed according to two-dimensional hexagonal p6mm symmetry, with a well-defined SBA-15 mesostructure (Figure 3a) , which is in agreement with the previously reported pattern for the same type silica material [23] .
The diffraction patterns of modified silica before and after drug loading (Figure 2b and   3c ) indicate that the long-range hexagonal symmetry of SBA-15 is preserved after modifications with TPA chains. A slight decrease in intensity of these characteristic diffraction planes after modification or drug loading is due to contrast matching between the silicate framework and the anchored TPA bridges or loaded drug molecules [24] . The d100 spacing at the (100) plane was calculated using Bragg's law as given in Equation 4:
where, λ is the wavelength and θ is the angle of incidence. The unit cell parameter (a 0 ) was calculated using Equation 5 and found to be 15.2 nm for both silicas.
Please insert Figure 3 here.
Nitrogen Sorption/Desorption
The nitrogen sorption/desorption isotherms of SBA-15 and modified silica SBA-15TPA are shown in Figure 4 . The hysteresis loops with sharp adsorption and desorption branches, indicatives of a narrow mesopores size distribution and shows a typical characteristic type IV isotherm with H1 hysteresis loop [26] . The amount of sorbed volume increased significantly to relative pressure (p/p 0 ), which is due to capillary condensation of nitrogen within the mesopores. while, the BJH average pore diameter of modified silica (7.1 nm) was not changed significantly when compared to original precursor silica (7.2 nm). The pore wall thickness Pw was calculated using Equation 5 and were estimated to be 8.0 and 7.9 nm for SBA-15 and modified silica, respectively.
where, (Dp) is the pore diameter obtained from nitrogen sorption/desorption and a0 was calculated from the XRD data.
Please insert Figure 4 here.
Scanning and Transmission electron microscopy
The surface morphologies of the synthesized materials were investigated with both scanning electron microscopy (SEM) and transmission electron microscopy (TEM) as shown in Figure 5 . The SEM images of SBA-15 ( Figure 5A ) show a channel-like porous structure with long fibrous macrostructures which is a characteristic morphology of SBA-15 type silica [17, 24] .
SEM for modified and IBU loaded silicas showed the same pattern morphological pattern ( Figure 5B & C) . The size, shape of particles and agglomerates suggested highly ordered mesoporous fiber like structures and confirm that the original morphology of SBA-15 remained preserved after modification.
TEM image of SBA-15 ( Figure 5D ) showed bright and dark area correspond to pores and walls confirming well-ordered hexagonal arrays of mesopores (1D channel) and 2D p6mm hexagonal structure [27] . The distance between mesopores was estimated to be 7 to 10 nm for silica SBA-15 ( Figure 5D ), which is in agreement with SAXS data.
Please insert Figure 5 here.
Thermogravimetry
The thermogravimetric curves (TG) recorded for SBA-15 and SBA-15TPA are shown in Figure 6 . TG curve of SBA-15 showed two distinct mass loss regions: i) in the temperature range from 314 to 335 K that correspond to 10% of total mass loss and ii) a slight decrease in mass of about 0.51% in the 335-1200 K range. The first event can be attributed to evaporation/decomposition of water and solvent molecules and the second event could be assigned to silanol condensation [27, 28] .
The DTG curve obtained for the chemically modified silica SBA-15TPA (Figure 6 Please insert Figure 6 here.
Zeta potential
The zeta potential of silica SBA-15 and modified silica SBA-15TPA suspended in aqueous medium was measured and compared. The ζ changed from -19 to +45.7 mV after modification.
This high zeta potential value confirmed the modification process and also suggests the coverage of silica surface with basic -NH groups.
Drug loading and in vitro release
The nature of drug, physiological conditions, drug matrix interaction, surface charges and pore diameter in case of porous materials play a vital role in drug loading and release processes.
At lower pH ibuprofen (pKa 4.91) dissociates to yields negatively charged carboxylate ions (COO -) and form strong bonding with free silanol (-Si-OH) or amine groups ( _ N + ) of the anchored organic functional groups [28] . The amount of drug loaded by both unmodified (18%) and modified (22%) silicas indicated that the attached functional groups and mesoporous structure are responsible in the drug loading process.
In vitro drug release profiles (% Mass/Mass) from silica systems in biological fluids (up to 8.5 h and complete release profile up to 75. 5 h) are shown in Figure 7A and 7B. Initially, burst release (about 28% in 8.5 h) was observed from unmodified silica SBA-15 in both SBF and SIF. After surface modification with amine linkers the drug release was slow and about 19 to 20 % of the total drug was released during 8.5 h in SBF and SIF, respectively. While in simulated gastric fluid (SGF 0.10 mol dm -3 HCl, pH 1.2) a slow release pattern (>10% Mass/Mass) was observed from both unmodified and modified silicas, which could be possible due to i) adhesion of drug molecules into micro/mesopores of silica and ii) strong hydrogen bonding between surface silanols groups (-Si-OH) of SBA-15 or amine groups ( _ N + ) of the modified silica with dissociated drug molecules of ibuprofen in strong acidic medium [29] .
When the release medium was changed to simulated body fluid (SBF, pH 7.2, USP) at this pH condition, the low H+ concentration favor the release of drug to medium, resulting in high release rate. In simulated intestinal fluid (SIF, Phosphate Buffer, pH 6.8) protons (H+)
produced from drug dissociation can be partially consumed due to buffer action which can shift the equilibrium from surface to the release medium [28, 29] and increase the drug solubility in comparison to other fluids. From the drug release profiles it is clear that the release equilibrium rates of SBA-15 are much faster than that of the modified silica with amine linkers (Figure 7 ).
Hydrogen bonding between ibuprofen and parent silica material is relatively weaker, than that of -COO -NH + bond of the modified silica and the release of IBU through the mesoporous channels is controlled by diffusion. The drug release process was gradually fallen after 24 and the release rate remained constant up to 75.5 h ( Figure 7B ).
Please inert Figure 7 here.
Release mechanism
The drug release mechanism from mesoporous silicas was investigated with zero order and first order kinetic models [30] , Higuchi [31] , Hixson Crowell [32] , Korsmeyer-Peppas [31- 34] models as given in Equations 7-11.
Zero order model: =
First order model:
Higuchi model:
Hixson-Crowell model:
Korsmeyer-Peppas model:
where in these equations Mi/Mt is the fractional active agents released at time t, k is rate constant and n is an indication of such mechanism. The correlation coefficient R 2 values obtained with Equations 7-11 are given in Table 1 Korsmeyer-Peppas model:
where, Mt and M∞ are the masses of drug released at time t and at infinite time respectively, k is kinetic constant and diffusional exponent n is used to characterize the mechanism. For tablets, (depending on the diameter-thickness ratio) the Fickian diffusion is described by 0.43 < n < 0.50 and 0.45 <n < 0.89 corresponds to a non-Fickian or anomalous diffusion. The n value of about 0.89 is an indicative of case II transport and for n > 0.89 is typical zero-order release [29] .
The correlation coefficient (R 2 ), diffusion exponent n and rate constant k values obtained from nonlinear fit of Korsmeyer-Peppas model (Equation 12) are given in Table 1 . Exponent n value less than 0.45 illustrated less Fickian diffusion mechanism of ibuprofen from both silicas.
The small k values at lower pH condition (pH 1.2) indicate the slow release rate of ibuprofen from silica systems (due to protonation of IBU in acidic medium that ultimately increased the drug-silica interactions and resulted in slow diffusion rate). The large k values obtained for high pH conditions illustrated the unrestricted diffusion of ibuprofen from silica systems to the dissolution medium (SBF, pH 7.2 and SIF pH 6.8). The modeling of the Korsmeyer-Peppas suggests that the drug release mechanism was more diffusion based due to highly accessible nano-reservoir of the silica materials.
Please insert Table 1 here.
Conclusion
Mesoporous silica SBA-15 and its derivative SBA-15TPA was synthesized and characterized using sol gel method. Surface modification of the precursor silica with the synthesized long hydrophobic bridges improved the drug loading capacity and also affected the in vitro release profiles. Ibuprofen can make strong bonding with free silanol (-Si-OH) and amine groups (-N + ) of the anchored organic functional groups this phenomenon was observed at pH 1.2 conditions. The slow release kinetics at this pH favors to prevent the premature elimination of ibuprofen while passing through stomach that could enhance the drug availability at the desired site. The drug release mechanism from synthesized carriers was investigated with various kinetic models. The high correlation coefficient (R 2 ) and diffusion exponent n value less Transmittance / a.u.
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